The cancer- and NS-associated mutations in PTPN11 occur at the interface between the N-terminal SH2 domain at residues D62, Y63 or Q79, and in the PTP domain at residue N308, and relieve auto-inhibitory intramolecular interactions (Table 1; Fig. S1). This evidence concerns the gene PTPN11 and cancer.